Autopsy report · NCT02465957
QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC)
Cause of deathNo reason given
Life of this trial
- Registered 4 months before it started.
- Ran for about 2 years 6 months before it stopped.
- 7 participants enrolled.
- Results were posted on the registry 6 years 1 month after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- ImmunityBio, Inc.
- Sponsor type
- Industry
- Conditions
- Stage IIIB Merkel Cell Carcinoma; Stage IV Merkel Cell Carcinoma
- Interventions
- aNK (NK-92); aNK (NK-92) + N-803
- Participants
- 7
- Sites
- 3
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.